Publication | Open Access

A selective cyclin-dependent kinase 4, 6 dual inhibitor, Ribociclib (LEE011) inhibits cell proliferation and induces apoptosis in aggressive thyroid cancer

Dual InhibitorOncologyMedicineReceptor Tyrosine KinaseCell DeathAggressive Thyroid CancerCell ProliferationAnti-cancer AgentTumor SuppressorPharmacologyCell BiologyCancer Research